Reading Biotechnology
Every news story we’ve published under Biotechnology — breaking headlines, analyst commentary, and press releases.
Biotechnology
Alteogen Signs An Exclusive Agreement With A Global Pharmaceutical Company To Develop And Commercialize A Hybrozyme-Based Subcutaneous Biologic Medicine
Alteogen Inc., a South Korean biopharmaceutical company, has signed an exclusive agreement with a global pharmaceutical company to develop as well as sell as subcutaneous…
View more →
Enzene Released Nex, A New Set Of Solutions That Helps Companies Build Local Biomanufacturing Facilities
Enzene, an India-based biopharmaceutical manufacturing company, released NeX on August 3, 2026. It is a partnership program that aid government authorities, institutions, and…
View more →
Biocon Launched Yesafili, A New Biosimilar Medicine In The U.S. That Is Similar To Regeneron’s Eylea 2 MG
Biocon Limited, a global biopharmaceutical company, released Yesafili (aflibercept-jbvf) in the United States. Yesafili is a biosimilar medicine same as Eylea 2 mg and is used to…
View more →
Samsung Biologics plans to buy PolyPeptide with a cash deal. This will help the company grow its business and expand its operations in the U.S., Europe, and India
Samsung Biologics has offered to buy 100% of PolyPeptide, a company that makes peptide-based medicines, for about CHF 1.46 billion in cash. Shareholders will receive CHF 44.31 for…
View more →
FUJIFILM Biosciences and NextCell have started a new commercial platform with RUO stromal cells and cell culture media
FUJIFILM Biosciences, a global life sciences company, along with NextCell Pharma AB, a cell therapy company, released a new global product together. It includes FUJIFILM’s…
View more →
Telix and Regeneron say they will work together on new radiopharmaceutical medicines
Telix Pharmaceuticals and Regeneron Pharmaceuticals say they will work together to make and sell new radiopharmaceutical medicines. Telix will bring its experience in making…
View more →
Cellipont Bioservices and Soter Bio have announced a partnership to help improve cell therapy manufacturing in the U.S.
Cellipont Bioservices, a company that specializes in cell therapy manufacturing , has teamed up with Soter Bio, a company that focuses on RNA and RNA-lipid nanoparticle…
View more →
Parse Biosciences Launches Evercode Whole Transcriptome v4
Parse Biosciences, a QIAGEN company, unveiled a new product called Evercode™ Whole Transcriptome v4. This product improves single-cell RNA sequencing by offering better…
View more →
Samsung Bioepis says it will sell its eye drug copy, Opuviz, in the United States in 2027
Samsung Bioepis, a division of Samsung Group focused on developing biosimilar drugs, announced its plans to launch its ophthalmology biosimilar, Opuviz, in the United States in…
View more →
CEPI and Samsung Biologics are Working Together to Improve the Production of Vaccines for Future Outbreaks and Make them More Accessible Worldwide
CEPI and Samsung Biologics have teamed up to improve vaccine production for future disease outbreaks as well as make sure people in all countries can get them. The goal is to…
View more →
SK Bioscience has opened a new research and development center in South Korea
SK Bioscience, the biotech part of South Korea's SK Group, opened a new global research and development center to improve its vaccine research. The center, located in Songdo, a…
View more →
Samsung Biologics will start offering a service for ADC (antibody-drug conjugate) drugs in 2027
Samsung Biologics is planning to start offering a service for antibody-drug conjugate (ADC) drugs in the first quarter of 2027. This move is part of the company’s efforts to…
View more →
VarmX and Rentschler Biopharma Collaborate to Develop New Coagulation Therapy for Phase 3 and Market Launch
Rentschler Biopharma, a global leader in contract development and manufacturing of biopharmaceuticals , has teamed up with VarmX, a biotech company working on new treatments for…
View more →
Insilico Medicine has Announced a Multi-Year Collaboration worth USD 888 Million with Servier to Work Together on Discovering and Developing New Cancer Treatments
Insilico Medicine, a prominent company utilizing artificial intelligence (AI) for drug discovery , has unveiled a multi-year partnership with Servier, a global pharmaceutical…
View more →
ImmunoForge Will Hold Meetings with Partners at the J.P. Morgan Healthcare Conference 2026
ImmunoForge, a biopharmaceutical company focused on rare diseases, announced that its leaders will be in San Francisco for the 43rd Annual J.P. Morgan Healthcare Conference from…
View more →
RiceTec and Horizon Ag to Release New ACCase Rice Varieties in 2026
Rice farmers who use ACCase or IMI herbicides to fight weed resistance can look forward to new rice varieties and more seed options in 2026. Two companies, RiceTec and Horizon Ag,…
View more →